venBio Partners’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
Other funds holding LSTA
SFCM
venBio Partners's LSTA Position: Q3 2026 in Review
venBio Partners opened a new position in Lisata Therapeutics (LSTA) in Q3 2026: 156,460 shares worth $225K. The stake represents 0.05% of the portfolio and ranks #9 among its holdings.
38 funds tracked by Wall St. Rank hold LSTA as of Q3 2026.
- venBio Partners held 156,460 shares of Lisata Therapeutics worth $225K as of Q3 2026.
- Lisata Therapeutics was a new venBio Partners position in Q3 2026.
- Lisata Therapeutics made up 0.05% of venBio Partners's portfolio in Q3 2026, its #9 holding.
- 38 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2026.
Based on venBio Partners's 13F filing for Q3 2026, filed 16 Nov 2026.